DocMorris rises on 'strong' Q1 results

DocMorris AG

16/04/2026 07:47

** Swiss online drug retailer DocMorris' DOCM.S stock is seen up 4.75% in Julius Baer premarket trade after the company released Q1 results, at the upper end of the company's guidance

** DocMorris achieved for Q1 an external group revenue growth of 10.7% yoy to 318.1 million Swiss francs  ($407.19 million), as the company's external revenue growth guidance in the mid-single-digit to low teens percentage range

** "A strong start to the year, primarily driven by the successful rollout of bonus incentives on co-payments," Jefferies writes

** DocMorris shares are down 3.53% YTD as of Wednesday’s close

($1 = 0.7812 Swiss francs)

 (Reporting by Tristan Veyet)

 ((Tristan.veyet@thomsonreuters.com))